Cancer Research UK logo.
Search
  • Search
A researcher working in the lab with a white lab coat with the Cancer Research UK logo.

Our research into brain and nerve cell tumours

Our research is saving lives

Brain tumours are one of the hardest types of cancer to treat and survival has barely improved over the last 40 years. Some types of nerve cell cancer, for example neuroblastoma, can be very difficult to treat too. Tackling brain and nerve cell tumours is a big challenge, but we are determined to improve the outlook for people with aggressive types of these diseases.

Researchers discussing brain images at a desk.

Current research

From studying the biology of brain and nerve cell tumour cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive.

Find out more about our current research

Microscope in a lab.

Past research

Thanks to research, we’ve helped change the outlook for people with brain and nerve cell tumours.

Find out more about past research

Explore our timeline of research into brain and nerve cell tumours

Rhys - a brain and nerve cancer patient, smiling and holding a teddy.

Patients' stories

Meet people like Rhys who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.

Read stories from brain and nerve cell tumour patients

Our strategy

Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.

We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.

Read more about our strategy

Cancer News

Cancer News

Browse the latest news, analysis and opinion from Cancer Research UK.

Further information

Want to find more information about our research or brain and nerve cell tumours?

Find out more about clinical trials

More about the symptoms and treatments for brain tumours

More about different nerve cell tumours